Skip Navigation



Human Molecular Genetics Advance Access published online on August 12, 2003
Human Molecular Genetics, doi:10.1093/hmg/ddg271
© 2003 by Oxford University Press
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
12/suppl_2/R187    most recent
ddg271v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Marsh, J. L.
Right arrow Articles by Thompson, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marsh, J. L.
Right arrow Articles by Thompson, L. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

©2003 Oxford University Press

Article

FLY MODELS OF HUNTINGTON'S DISEASE

J. Lawrence Marsh 1*, Judit Pallos 1, and Leslie M. Thompson 2

1 Department of Developmental and Cell Biology, 4244 McGaugh Hall, University of California, Irvine, CA 92697-2300, USA
2 Department of Psychiatry and Human Behavior, Gillespie 2121, University of California, Irvine, CA 92697-4260, USA

* To whom correspondence should be addressed. E-mail: jlmarsh{at}uci.edu.


  Abstract

Can Drosophila models be engineered that accurately reflect Huntington's disease [HD] and other neurological diseases and can they contribute to the search for treatments and cures? A number of publications seem to provide a resounding yes to that question. Here we seek to review some of the salient features of these models.

Key Words: Drosophila, polyglutamine, Huntington's disease, neurodegeneration


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
C. T. Aiken, J. S. Steffan, C. M. Guerrero, H. Khashwji, T. Lukacsovich, D. Simmons, J. M. Purcell, K. Menhaji, Y.-Z. Zhu, K. Green, et al.
Phosphorylation of Threonine 3: IMPLICATIONS FOR HUNTINGTIN AGGREGATION AND NEUROTOXICITY
J. Biol. Chem., October 23, 2009; 284(43): 29427 - 29436.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
J. Pallos, L. Bodai, T. Lukacsovich, J. M. Purcell, J. S. Steffan, L. M. Thompson, and J. L. Marsh
Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington's disease
Hum. Mol. Genet., December 1, 2008; 17(23): 3767 - 3775.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
J.-C. Lievens, T. Rival, M. Iche, H. Chneiweiss, and S. Birman
Expanded polyglutamine peptides disrupt EGF receptor signaling and glutamate transporter expression in Drosophila
Hum. Mol. Genet., March 1, 2005; 14(5): 713 - 724.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.